These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39016455)

  • 1. Editorial Comment: Ablation for Early-Stage Hepatocellular Carcinoma Results in Lower Costs Relative to Both Surgical Resection and Transplant.
    Dabiri BE
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431657. PubMed ID: 39016455
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos RC; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431272. PubMed ID: 38899842
    [No Abstract]   [Full Text] [Related]  

  • 4. Downstaging hepatocellular carcinoma prior to liver transplantation.
    Gamblin TC; Geller DA
    Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
    [No Abstract]   [Full Text] [Related]  

  • 5. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
    Landman MP; Feurer ID; Pinson CW; Moore DE
    HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma.
    Zaydfudim V; Whiteside MA; Griffin MR; Feurer ID; Wright JK; Pinson CW
    Ann Surg Oncol; 2010 Dec; 17(12):3104-11. PubMed ID: 20585872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single HCC between 2 and 5 cm: the grey zone: surgeon's perspective.
    Hasegawa K; Kokudo N; Sano K; Makuuchi M
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):430-3. PubMed ID: 19890599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3-5 cm): a Propensity Score Matching Cohort Study.
    Ye QW; Pang SJ; Yang N; Zhang HB; Fu Y; Lin B; Yang GS
    J Gastrointest Surg; 2019 Aug; 23(8):1549-1558. PubMed ID: 31197690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma.
    Fujita T
    J Hepatol; 2009 May; 50(5):1051-2; author reply 1052-3. PubMed ID: 19329216
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatments for Early Hepatocellular Carcinoma: Resection or Ablation-How to Make a Decision.
    Zheng J; Wang Y; Jiang L
    J Am Coll Radiol; 2024 Sep; 21(9):1330-1331. PubMed ID: 38719099
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiofrequency ablation of hepatocellular carcinoma].
    Widmann G; Schullian P; Bale R
    Wien Med Wochenschr; 2013 Mar; 163(5-6):132-6. PubMed ID: 23515886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical therapy of hepatocellular carcinoma.
    McCormack L; Petrowsky H; Clavien PA
    Eur J Gastroenterol Hepatol; 2005 May; 17(5):497-503. PubMed ID: 15827439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
    Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to do: Radiofrequency thermal ablation].
    Schultheiß M; Thimme R
    Dtsch Med Wochenschr; 2015 Jan; 140(1):36-8. PubMed ID: 25580971
    [No Abstract]   [Full Text] [Related]  

  • 16. Resection and radiofrequency ablation for hepatocellular cancer.
    Jain A
    J Surg Res; 2014 Oct; 191(2):309-10. PubMed ID: 25103638
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy.
    Llovet JM; Bruix J; Gores GJ
    Hepatology; 2000 Apr; 31(4):1019-21. PubMed ID: 10733561
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical treatment of hepatocellular cancer: expert consensus conference.
    Aloia TA; Hemming A; Schwartz M
    HPB (Oxford); 2010 Jun; 12(5):311-2. PubMed ID: 20590904
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and Safety of Radiofrequency Ablation versus Liver Resection in the Treatment of Early-stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Xu Z; Hu Y; Huang L
    Ann Ital Chir; 2024; 95(2):109-118. PubMed ID: 38684504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Ablation Does Not Worsen Perioperative Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    de Haas RJ; Lim C; Ricci C; Lahat E; Fuentes L; Salloum C; Azoulay D
    AJR Am J Roentgenol; 2019 Sep; 213(3):702-709. PubMed ID: 31120785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.